131 related articles for article (PubMed ID: 1437714)
21. Increased feeding and neuropeptide Y (NPY) but not NPY mRNA levels in the hypothalamus of the rat following central administration of the serotonin synthesis inhibitor p-chlorophenylalanine.
Dryden S; Frankish HM; Wang Q; Williams G
Brain Res; 1996 Jun; 724(2):232-7. PubMed ID: 8828573
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of hypothalamic neuropeptide Y gene expression by insulin.
Schwartz MW; Sipols AJ; Marks JL; Sanacora G; White JD; Scheurink A; Kahn SE; Baskin DG; Woods SC; Figlewicz DP
Endocrinology; 1992 Jun; 130(6):3608-16. PubMed ID: 1597158
[TBL] [Abstract][Full Text] [Related]
23. Increased hypothalamic neuropeptide Y concentration or hyperphagia in streptozotocin-diabetic rats are not mediated by glucocorticoids.
Dryden S; Burns SJ; Frankish HM; Williams G
Eur J Pharmacol; 1997 Dec; 340(2-3):221-5. PubMed ID: 9537819
[TBL] [Abstract][Full Text] [Related]
24. Metabolic and orexigenic effects of intracerebroventricular neuropeptide Y are attenuated by food deprivation.
Parikh R; Marks JL
J Neuroendocrinol; 1997 Oct; 9(10):789-95. PubMed ID: 9355048
[TBL] [Abstract][Full Text] [Related]
25. Hypothalamic insulin and neuropeptide Y in the offspring of gestational diabetic mother rats.
Plagemann A; Harder T; Rake A; Melchior K; Rittel F; Rohde W; Dörner G
Neuroreport; 1998 Dec; 9(18):4069-73. PubMed ID: 9926849
[TBL] [Abstract][Full Text] [Related]
26. Hypoleptinemia, but not hypoinsulinemia, induces hyperphagia in streptozotocin-induced diabetic rats.
Hidaka S; Yoshimatsu H; Kondou S; Oka K; Tsuruta Y; Sakino H; Itateyama E; Noguchi H; Himeno K; Okamoto K; Teshima Y; Okeda T; Sakata T
J Neurochem; 2001 May; 77(4):993-1000. PubMed ID: 11359864
[TBL] [Abstract][Full Text] [Related]
27. Involvement of hypothalamic neuropeptide Y in regulating the amphetamine-induced appetite suppression in streptozotocin diabetic rats.
Kuo DY
Regul Pept; 2005 Apr; 127(1-3):19-26. PubMed ID: 15680466
[TBL] [Abstract][Full Text] [Related]
28. Effect of a high-fat diet on food intake and hypothalamic neuropeptide gene expression in streptozotocin diabetes.
Chavez M; Seeley RJ; Havel PJ; Friedman MI; Matson CA; Woods SC; Schwartz MW
J Clin Invest; 1998 Jul; 102(2):340-6. PubMed ID: 9664075
[TBL] [Abstract][Full Text] [Related]
29. Treadmill exercise suppresses diabetes-induced increment of neuropeptide Y expression in the hypothalamus of rats.
Shin MS; Kim H; Chang HK; Lee TH; Jang MH; Shin MC; Lim BV; Lee HH; Kim YP; Yoon JH; Jeong IG; Kim CJ
Neurosci Lett; 2003 Aug; 346(3):157-60. PubMed ID: 12853108
[TBL] [Abstract][Full Text] [Related]
30. Increased neuropeptide Y concentrations in specific hypothalamic nuclei of the rat following treatment with methysergide: evidence that NPY may mediate serotonin's effects on food intake.
Dryden S; McCarthy HD; Malabu UH; Ware M; Williams G
Peptides; 1993; 14(4):791-6. PubMed ID: 8234027
[TBL] [Abstract][Full Text] [Related]
31. Evidence that hypothalamic neuropeptide Y gene expression and NPY levels in the paraventricular nucleus increase before the onset of hyperphagia in experimental diabetes.
Sahu A; Sninsky CA; Kalra SP
Brain Res; 1997 May; 755(2):339-42. PubMed ID: 9175903
[TBL] [Abstract][Full Text] [Related]
32. Increased endogenous noradrenaline and neuropeptide Y release from the hypothalamus of streptozotocin diabetic rats.
Morris MJ; Pavia JM
Brain Res; 2004 Apr; 1006(1):100-6. PubMed ID: 15047028
[TBL] [Abstract][Full Text] [Related]
33. Agouti-related protein is a mediator of diabetic hyperphagia.
Qu SY; Yang YK; Li JY; Zeng Q; Gantz I
Regul Pept; 2001 Apr; 98(1-2):69-75. PubMed ID: 11179781
[TBL] [Abstract][Full Text] [Related]
34. Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats.
Sahu A; Sninsky CA; Phelps CP; Dube MG; Kalra PS; Kalra SP
Endocrinology; 1992 Dec; 131(6):2979-85. PubMed ID: 1446635
[TBL] [Abstract][Full Text] [Related]
35. Altered neuropeptide Y concentrations in specific hypothalamic regions of obese (fa/fa) Zucker rats. Possible relationship to obesity and neuroendocrine disturbances.
McKibbin PE; Cotton SJ; McMillan S; Holloway B; Mayers R; McCarthy HD; Williams G
Diabetes; 1991 Nov; 40(11):1423-9. PubMed ID: 1657667
[TBL] [Abstract][Full Text] [Related]
36. Hypothalamic ghrelin treatment modulates NPY-but not CRH-ergic activity in adrenalectomized rats subjected to food restriction: Evidence of a novel hypothalamic ghrelin effect.
Spinedi E; Voirol MJ; Verdumo C; Giacominni M; Pralong F; Gaillard RC
Endocrine; 2006 Jun; 29(3):477-84. PubMed ID: 16943587
[TBL] [Abstract][Full Text] [Related]
37. Hypothalamic neuropeptide Y (NPY) and the attenuation of hyperphagia in streptozotocin diabetic rats treated with dopamine D1/D2 agonists.
Kuo DY
Br J Pharmacol; 2006 Jul; 148(5):640-7. PubMed ID: 16702993
[TBL] [Abstract][Full Text] [Related]
38. Hypothalamic neuropeptide Y disturbances in the obese (cp/cp) JCR:LA corpulent rat.
Williams G; Shellard L; Lewis DE; McKibbin PE; McCarthy HD; Koeslag DG; Russell JC
Peptides; 1992; 13(3):537-40. PubMed ID: 1523165
[TBL] [Abstract][Full Text] [Related]
39. Role of ghrelin in streptozotocin-induced diabetic hyperphagia.
Ishii S; Kamegai J; Tamura H; Shimizu T; Sugihara H; Oikawa S
Endocrinology; 2002 Dec; 143(12):4934-7. PubMed ID: 12446621
[TBL] [Abstract][Full Text] [Related]
40. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice.
Schwartz MW; Baskin DG; Bukowski TR; Kuijper JL; Foster D; Lasser G; Prunkard DE; Porte D; Woods SC; Seeley RJ; Weigle DS
Diabetes; 1996 Apr; 45(4):531-5. PubMed ID: 8603777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
